繁體
简体中文
繁體中文

FUNDX ETF XCOR

等待開盤 09-09 09:30:00 美东时间

76.654

+0.477

+0.63%

华盛通華盛通
立即下載
  • 最 高76.654
  • 今 開76.55
  • 成交量 216股
  • 最 低 76.55
  • 昨 收 76.1774
  • 總市值 1.71亿
  • 52周最高 76.654
  • 市盈率 --
  • 換手率 0.01%
  • 52周最低 56.59
  • 委 比 0.00%
  • 總股本 223.21万
  • 歷史最高 76.654
  • 量 比 0.09
  • 振 幅 0.14%
  • 歷史最低 44.3101
  • 每 手 1
  • 風險率 3.78%

個股概要

財務分析

公司資料

相關新聞

分紅派息

  • 分時圖
  • 日k
  • 周k
  • 月k

相關新聞

更多
  • Fulcrum Therapeutics to Present at Upcoming Investor Meetings

    Fulcrum Therapeutics announced that its management will participate in two investor conferences in New York, September 4 and 9, 2025, featuring fireside chats and company presentations. The sessions will be webcast live with replays available on their Investor Relations page. Fulcrum specializes in developing small molecules for rare genetic diseases, with its lead program pociredir targeting sickle cell disease by increasing fetal hemoglobin. In...

    08-26 12:00

  • AXIL Signs Agreement With Beretta Hellas LTD To Distribute AXIL Hearing Protection And Enhancement Products In Greece

    AXIL Brands, Inc. ("AXIL," "we," "us," "our," or the "Company") (NYSE:AXIL), an emerging global consumer products company for AXIL® hearing protection and enhancement products and Reviv3® hair and skin care

    2024-04-15 20:34